The following shareholders hold in excess of 3% or more of the Company’s issued share capital (PROFORMA):

Institutional Shareholder Number of Shares  % of Issued Share Capital
Woodford Investment Management 26,999,540 27.56%
Invesco Asset Management 19,149,176 19.90%
Novartis Pharma AG 15,703,871 16.03%
Canaccord Genuity Wealth Mgt 2,870,000 3.00%

The Directors hold the following shareholding interest in the company: 

Directors  Number of Shares % of Issued Share Capital
Kunal Kashyap 1,497,735 1.56%
Deepa Pakianathan* 1,283,670** 1.34%
Denise Scots-Knight 844,499 0.88%
Peter Bains   107,906 0.11%
Anders Ekblom 93,002 0.10%
Paul Blackburn 22,624 0.02%
Peter Fellner 10,000 0.01%

*as a General Partner of Delphi Ventures
**1,283,670 ordinary shares are held as ADSs

Issued share capital 97,959,622

Please visit our FAQs page.

Corporate Presentation

View our latest Corporate Presentation

View Presentation

AIM Share Price Chart

Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.

View Share Price chart

NASDAQ Share Price Chart

Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.

View share price chart